Glucagon Signaling Pathway

NewsGuard 100/100 Score

Glucagon is a hormone that counter-regulates insulin and sustains glucose homeostasis to prevent hypoglycemia. The action of the two hormones is crucial to maintaining glucose homeostasis.

Credit: Norbert Lange/

Glucagon increases the production of glucose by increasing glycogenolysis and gluconeogenesis in the liver, and by reducing glycogenesis and glycolysis. The release of glucagon in response to food consumption depends on the type of meal that has been eaten. If a meal is rich in carbohydrates, blood glucagon levels fall to prevent an undue rise in the level of circulating glucose. When a protein-rich meal is eaten, the blood glucagon level rises.

Glucagon production

In a part of the pancreas called the islets of Langerhans, the precursor, proglucagon, is cleaved in specialized cells called the alpha cells by an enzyme called prohormone convertase 2 to become glucagon. In the nerve cells of the brain stem and in the intestinal cells, proglucagon is processed by prohormone convertase 1 to produce glucagon-like peptides 1 and 2, as well as other peptides. These peptides link to G-protein coupled receptors which have distinct responses.

Glucagon signaling pathway

When the blood glucose level is low, the pancreatic alpha cells secrete glucagon. When glucagon binds to its receptor, which is mainly located in the liver and kidney, it induces the receptor to undergo conformational changes. This causes heterotrimeric G proteins to be activated, mainly the Gs alpha subunit, which starts signaling to activate adenylyl cyclase enzymes.

This leads to the production of cAMP, which results in activation of the protein kinase A (PKA) pathway. In this pathway, PKA phosphorylates the enzyme phosphorylase kinase which in turn phosphorylates, and activates glycogen phosphorylase. The latter is the enzyme involved in the initial and rate-limiting stage of glycogenolysis where glycogen is broken down to produce glucose.

PKA activated by glucagon also prevents the production of glycogen because it induces the phosphorylation of the enzyme glycogen synthase, which is essential for the biosynthesis of glycogen.

Regulation of glucagon signaling

The enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFBPase) is another essential enzyme involved in glucose metabolism that is activated by PKA. The kinase part of this enzyme enables fructose-2,6-bisphosphate (F2,6P) to be produced.

This in turn modulates the metabolism of glucose by activating phosphofructokinase and inhibiting fructose bisphosphatase. Phosphofructokinase is required in the glycolysis pathway and bisphophatase in the gluconeogenesis pathway.  The phosphatase arm of PFKFBP transforms F2,6P into F6P. PKA phosphorylates the kinase, inactivating it, which leads to an increase in phosphatase activity. The subsequent decrease in F2,6P results in the inhibition of glycolysis with the promotion of gluconeogenesis.

Researchers also think the activation of PKA by glucagon triggers gluconeogenesis by affecting the levels of the enzymes glucose-6-phosphatase and phosphoenolpyruvate carboxykinase. Again, this is by the phosphorylation-induced activation of transcription factors or co-activators.

Insulin and glucagon

Last Updated: Feb 26, 2019

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, February 26). Glucagon Signaling Pathway. News-Medical. Retrieved on May 18, 2024 from

  • MLA

    Robertson, Sally. "Glucagon Signaling Pathway". News-Medical. 18 May 2024. <>.

  • Chicago

    Robertson, Sally. "Glucagon Signaling Pathway". News-Medical. (accessed May 18, 2024).

  • Harvard

    Robertson, Sally. 2019. Glucagon Signaling Pathway. News-Medical, viewed 18 May 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Effect of mutations in cancer-driving genes across human cancers